ATE153657T1 - Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe - Google Patents
Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffeInfo
- Publication number
- ATE153657T1 ATE153657T1 AT93921480T AT93921480T ATE153657T1 AT E153657 T1 ATE153657 T1 AT E153657T1 AT 93921480 T AT93921480 T AT 93921480T AT 93921480 T AT93921480 T AT 93921480T AT E153657 T1 ATE153657 T1 AT E153657T1
- Authority
- AT
- Austria
- Prior art keywords
- benzylimido
- benzylamido
- antipsychotic
- benzylamino
- actives
- Prior art date
Links
- -1 BENZYLAMINO Chemical class 0.000 title 1
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/943,846 US5314885A (en) | 1992-09-11 | 1992-09-11 | Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE153657T1 true ATE153657T1 (de) | 1997-06-15 |
Family
ID=25480369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93921480T ATE153657T1 (de) | 1992-09-11 | 1993-09-10 | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5314885A (de) |
| EP (1) | EP0660822B1 (de) |
| JP (1) | JP3240143B2 (de) |
| AT (1) | ATE153657T1 (de) |
| CA (1) | CA2144344C (de) |
| DE (1) | DE69311123T2 (de) |
| DK (1) | DK0660822T3 (de) |
| ES (1) | ES2104174T3 (de) |
| GR (1) | GR3023757T3 (de) |
| NZ (1) | NZ256263A (de) |
| WO (1) | WO1994006768A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA954688B (en) | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | Serotonin 5-HT1A and dopamin D2 receptor ligands |
| WO1996014297A1 (en) * | 1994-11-04 | 1996-05-17 | Sumitomo Pharmaceuticals Company, Limited | Novel lactam derivatives |
| US5744472A (en) * | 1995-06-05 | 1998-04-28 | Neurogen Corporation | 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
| US5859246A (en) * | 1997-01-30 | 1999-01-12 | Neurogen Corporation | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands |
| US6313141B1 (en) | 1997-06-13 | 2001-11-06 | Neurogen Corporation | 2-aminoalkylaminoquinolines as dopamine D4 ligands |
| US5972945A (en) * | 1997-06-13 | 1999-10-26 | Neurogen Corporation | 2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligands |
| IL125951A (en) * | 1997-09-05 | 2003-09-17 | Pfizer Prod Inc | A pharmaceutical composition comprising a piperazinyl-heterocyclic compound for treating tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal |
| US6433338B1 (en) | 1998-02-09 | 2002-08-13 | Tomra Systems Asa | Method and device for identification of a type of material in an object and utilization therefor |
| US6613901B2 (en) | 2000-03-08 | 2003-09-02 | Neurogen Corporation | 2-aminoalkylaminoquinolines as dopamine D4 ligands |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE44528T1 (de) * | 1984-12-21 | 1989-07-15 | Duphar Int Res | Arzneimittel mit antipsychotischer wirkung. |
| ES2052545T3 (es) * | 1986-02-27 | 1994-07-16 | Duphar Int Res | (n-piperidinil)-metil- y (n-piperazinil)metilazoles sustituidos con arilo que tienen propiedades antipsicoticas. |
| EP0288575A4 (en) * | 1986-10-27 | 1990-10-10 | Yoshitomi Pharmaceutical Industries, Ltd. | Piperazine compounds and their medicinal use |
| US4992441A (en) * | 1987-10-14 | 1991-02-12 | Mcneilab, Inc. | 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia |
| US5087627A (en) * | 1989-03-15 | 1992-02-11 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of disorders of the cerebro-neural transmission system |
| GB9021453D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
| IE914218A1 (en) * | 1991-09-11 | 1993-03-24 | Mcneilab Inc | Novel 4-arylpiperazines and 4-arylpiperidines |
| US5254689A (en) * | 1992-02-25 | 1993-10-19 | American Home Products Corporation | Piperdinyl and piperazinyl derivatives |
-
1992
- 1992-09-11 US US07/943,846 patent/US5314885A/en not_active Expired - Lifetime
-
1993
- 1993-09-10 DK DK93921480.5T patent/DK0660822T3/da active
- 1993-09-10 US US08/120,015 patent/US5449677A/en not_active Expired - Lifetime
- 1993-09-10 WO PCT/US1993/008545 patent/WO1994006768A1/en not_active Ceased
- 1993-09-10 NZ NZ256263A patent/NZ256263A/en not_active IP Right Cessation
- 1993-09-10 AT AT93921480T patent/ATE153657T1/de not_active IP Right Cessation
- 1993-09-10 CA CA002144344A patent/CA2144344C/en not_active Expired - Fee Related
- 1993-09-10 JP JP50818294A patent/JP3240143B2/ja not_active Expired - Fee Related
- 1993-09-10 EP EP93921480A patent/EP0660822B1/de not_active Expired - Lifetime
- 1993-09-10 ES ES93921480T patent/ES2104174T3/es not_active Expired - Lifetime
- 1993-09-10 DE DE69311123T patent/DE69311123T2/de not_active Expired - Fee Related
-
1997
- 1997-06-11 GR GR970401401T patent/GR3023757T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3240143B2 (ja) | 2001-12-17 |
| ES2104174T3 (es) | 1997-10-01 |
| EP0660822B1 (de) | 1997-05-28 |
| CA2144344C (en) | 2004-11-09 |
| US5314885A (en) | 1994-05-24 |
| GR3023757T3 (en) | 1997-09-30 |
| DE69311123D1 (de) | 1997-07-03 |
| DE69311123T2 (de) | 1997-11-06 |
| WO1994006768A1 (en) | 1994-03-31 |
| EP0660822A1 (de) | 1995-07-05 |
| JPH08501548A (ja) | 1996-02-20 |
| CA2144344A1 (en) | 1994-03-31 |
| DK0660822T3 (da) | 1997-08-25 |
| US5449677A (en) | 1995-09-12 |
| NZ256263A (en) | 1996-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2134847T3 (es) | Derivados de taxol. | |
| MX9102407A (es) | 4 arilpiperazinas y 4-arilpiperidinas novedosas. | |
| DE69331774D1 (de) | 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel | |
| ATE303993T1 (de) | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe | |
| PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
| ATE205472T1 (de) | 9-((substituierte glycyl)amido)-6-demethyl-6- deoxytetracycline als antibiotische mittel | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| ATE206409T1 (de) | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide | |
| FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
| NO924598L (no) | Fremstilling av substituerte piperidiner | |
| ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| DE69528983D1 (de) | Indolalkaloide als antientzündliche wirkstoffe | |
| BR9206823A (pt) | Preparação de piperidinas substituídas | |
| NZ333281A (en) | Asymmetric stilbene compounds for use as sun protection agents | |
| ATE153657T1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe | |
| ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
| ES2123728T3 (es) | Derivados de pirrolo-pirazina de actividad 5-ht3. | |
| ATE165089T1 (de) | Thiocarbamoylverbindungen als mikrobizide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |